Rare diseases
Investigational molecules
Locations
Orforglipron for stress urinary incontinence in women with obesity or overweight
CzechiaStudy on the Effectiveness and Safety of Orforglipron for Weight Management in Adolescents with Obesity or Overweight
ItalyPhase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes
BelgiumA study to evaluate the efficacy and safety of orforglipron in patients with peripheral artery disease
FranceA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
AustriaA Study of Orforglipron for Knee Pain Relief in Adults with Obesity or Overweight and Knee Osteoarthritis
GermanyStudy of Orforglipron in Overweight Adults at Risk of Developing Obesity‑Related Complications or Class 1 Obesity
CzechiaStudy of Orforglipron for Weight Management in People with Obesity or Overweight, With or Without Type 2 Diabetes
CzechiaStudy of orforglipron in people with high blood pressure who are overweight or have obesity
CzechiaStudy on the Effectiveness of Orforglipron for Patients with Obstructive Sleep Apnea and Obesity or Overweight
CzechiaStudy Comparing Orforglipron and Dapagliflozin for Adults with Type 2 Diabetes and Poor Blood Sugar Control on Metformin
GermanyStudy of LY3502970 for Adults with Obesity or Overweight and Related Health Issues
SlovakiaTell us about your condition – we search every trial in Europe and connect you with the right site.
